MetLife Investment Management’s Celcuity CELC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Buy
19,094
+1,360
+8% +$148K 0.01% 1016
2025
Q4
$1.77M Buy
17,734
+693
+4% +$57K 0.01% 1142
2025
Q3
$842K Sell
17,041
-2,831
-14% -$113K ﹤0.01% 1553
2025
Q2
$265K Hold
19,872
﹤0.01% 2025
2025
Q1
$201K Sell
19,872
-512
-3% -$5.79K ﹤0.01% 2200
2024
Q4
$267K Buy
20,384
+6,669
+49% +$94.1K ﹤0.01% 2149
2024
Q3
$204K Hold
13,715
﹤0.01% 2277
2024
Q2
$225K Buy
13,715
+4,541
+49% +$76K ﹤0.01% 2167
2024
Q1
$198K Hold
9,174
﹤0.01% 2210
2023
Q4
$134K Hold
9,174
﹤0.01% 2462
2023
Q3
$83.8K Hold
9,174
﹤0.01% 2667
2023
Q2
$101K Buy
+9,174
New +$95.3K ﹤0.01% 2678

Other funds holding CELC

MetLife Investment Management's CELC Position: Q1 2026 in Review

MetLife Investment Management increased its Celcuity (CELC) stake by 7.7% in Q1 2026, buying an estimated $148K and bringing the position to 19,094 shares worth $2.18M. The position accounts for 0.01% of the portfolio, ranked #1016.

MetLife Investment Management first reported a position in CELC in Q2 2023 and has held it in 12 quarters since. 275 funds tracked by Wall St. Rank hold CELC as of Q1 2026.

  • MetLife Investment Management held 19,094 shares of Celcuity worth $2.18M as of Q1 2026.
  • MetLife Investment Management bought 1,360 Celcuity shares in Q1 2026, an estimated $148K.
  • Celcuity made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1016 holding.
  • MetLife Investment Management first reported a position in Celcuity in Q2 2023 and has held it in 12 quarters since.
  • 275 funds tracked by Wall St. Rank held Celcuity as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.